Rivaroxaban

Fa'amatalaga Puupuu:

Igoa API Fa'ailoga Fa'amatalaga US DMF EU DMF CEP
Rivaroxaban Anticoagulant I totonu o le Fale TDP    


Fa'amatalaga Oloa

Faailoga o oloa

FAAMATALAGA O MEA FAI

Talaaga

Rivaroxaban, 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2 -carboxamide, o se faʻamalosi laiti-molole inhibitor o mea Xa lea o se vaega coagulation i se juncture taua i le auala coagulation toto e mafua ai le gaosiga o le thrombin ma le fausia o clot.Rivaroxaban e fusifusia i le Tyr288 i le S1 taga o mea Xa e ala i le fegalegaleaiga a Tyr288 ma le chlorine suitulaga o le chlorothiophene moiety.O le faʻalavelave e mafai ona faʻafeiloaʻi (koff = 5x10-3s-1), vave (kon = 1.7x107 mol / L-1 s-1), ma i se tulaga faʻalagolago (Ki = 0.4 nmol / L).Rivaroxaban o loʻo suʻesuʻeina nei mo le togafitiga o le VTE, puipuia o mea e tutupu i le cardiovascular i tagata mamaʻi maʻi faʻamaʻi pipisi, puipuia o le stroke i tagata mamaʻi ma le fibrillation atrial.

Fa'asinomaga

Elisabeth Perzborn, Susanne Roehrig, Alexander Straub, Dagmar Kubitza, Wolfgang Mueck, ma Volker Laux.Rivaroxaban: o se mea fou ole fa'aogaina ole Xa inhibitor.Arterioscler Thromb Vasc Biol 2010;30(3): 376-381

Fa'amatalaga

Rivaroxaban (BAY 59-7939) e sili ona malosi,filifili ma tuusao Factor Xa (FXa) inhibitor, ausia se malosi malosi i le anti-FXa malosi (IC50 0.7 nM; Ki 0.4 nM).

 

I Vitro

Rivaroxaban (BAY 59-7939) o se fa'amalo tautala, Factor Xa (FXa) tuusaʻo i le atinaʻeina mo le puipuia ma le togafitia o le thrombosis arterial ma venous.Rivaroxaban fa'atauvaga fa'alavelave fa'alavelave FXa tagata (Ki 0.4 nM) fa'atasi ma> 10 000-sili atu le filifilia nai lo isi serine proteases;e taofia ai foi le gaioiga o le prothrombinase (IC50 2.1 nM).Rivaroxaban e faʻalavelaveina le endogenous FXa sili atu ona malosi i le plasma o le tagata ma le lapiti (IC50 21 nM) nai lo le plasma rat (IC50 290 nM).O loʻo faʻaalia ai aʻafiaga o le anticoagulant i le plasma tagata, faʻaluaina le taimi o le prothrombin (PT) ma faʻagaoioia le taimi o le thromboplastin i le 0.23 ma le 0.69.μM, ta'itasi.

 

Rivaroxaban (BAY 59-7939) o se malosi ma le filifilia, faʻatonu FXa inhibitor faʻatasi ma le sili ona lelei i le vivo gaioiga ma le lelei o le bioavailability oral.Rivaroxaban (BAY 59-7939), faʻatonuina e le iv bolus aʻo leʻi amataina le thrombus, faʻaitiitia le faʻavaeina o le thrombus (ED50 0.1 mg / kg), faʻalavelave FXa, ma faʻaumiina le fua o le PT faʻalagolago.O le PT ma le FXa e aafia laʻititi i le ED50 (1.8-faʻateleina faʻateleina ma 32% faʻasaina, faʻasologa).I le 0.3 mg / kg (dose e taʻitaʻia ai le faʻamaʻi atoa o le faʻavaeina o le thrombus), o Rivaroxaban e faʻalauteleina le PT (3.2).±0.5-paiga) ma faʻalavelaveina le gaioiga FXa (65±3%).

 

Teuina

Pa'u

-20°C

3 tausaga
 

4°C

2 tausaga
I solvent

-80°C

6 masina
 

-20°C

1 masina

Fa'asologa o vaila'au

Rivaroxaban

PULEGA UIGA

Quality management1

Fautuaga18Poloketi Iloiloga Tulaga Tulaga Lelei ua fa'amaonia4, ma6o lo'o i lalo le faamaoniga.

Quality management2

A'oa'oga fa'ava-o-malo pulega lelei faiga ua faataatia faavae mautu mo le faatauina atu.

Quality management3

O le va'aiga lelei e fa'atautaia i le taamilosaga atoa o le olaga o le oloa ina ia mautinoa le lelei ma le togafitiga.

Quality management4

E lagolagoina e le vaega o Mataupu Tau Fa'apolofesa tulaga mana'omia ile taimi ole talosaga ma le resitalaina.

PULEGA O GALUEGA

cpf5
cpf6

Korea Countec Laina Fa'a'u'u Fagu

cpf7
cpf8

Taiuani CVC Faunoa Laina afifiina

cpf9
cpf10

Italia CAM Board Packaging Line

cpf11

Siamani Fette Compacting Machine

cpf12

Iapani Viswill Tablet Su'esu'e

cpf14-1

Potu Pulea DCS

PAAGA

Felagolagomai faavaomalo
International cooperation
Felagolagomai i totonu o aiga
Domestic cooperation

  • Muamua:
  • Sosoo ai:

  • Tusi lau savali iinei ma lafo mai ia i matou

    Vaega o oloa